The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes

Rossella Ricci, Candida Palmero, Gyada Bazurro, Anna Maria Riccio, Valentina Garelli, Eddi Di Marco, Carmelina Cirillo, Fulvio Braido, Giorgio Walter Canonica, Giovanni Melioli

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The administration of a polyvalent mechanical bacterial lysate (PMBL) in elderly patients with COPD has been shown to reduce the number of exacerbation. This is largely related to the involvement of cells belonging to the innate and the adaptive immune system (including dendritic cells, granulocytes, T and B lymphocytes and NK cells) that actively cooperate inducing the production of specific opsonizing antibodies directed to the antigens of PMBL. We have evaluated the production of antibodies directed to respiratory and systemic pathogens in a group of elderly COPD patients, recruited in a clinical trial, ancillary to a larger multicenter double blind, placebo-controlled, parallel-designed clinical trial in which patients were randomized to daily receive either PMBL or placebo. The treated group not only experienced a reduced number of seroconversion, but also, better controlled the number of infectious episodes and COPD exacerbations. It was thus evident that the administration of PMBL resulted not only effective in inducing the secretion of specific antibodies, but also effective in reducing the infectious episodes trough the potentiation of the antibody-mediated arm of the immune response.

Original languageEnglish
Pages (from-to)109-113
Number of pages5
JournalPulmonary Pharmacology and Therapeutics
Volume27
Issue number1
DOIs
Publication statusPublished - Feb 2014

Fingerprint

Chronic Obstructive Pulmonary Disease
Antibodies
Placebos
Clinical Trials
Lymphocytes
Immune system
Pathogens
Granulocytes
Natural Killer Cells
Dendritic Cells
Antibody Formation
Immune System
B-Lymphocytes
T-Lymphocytes
Antigens
Broncho-Vaxom

Keywords

  • Antibodies
  • Chronic obstructive pulmonary disease
  • Immune response
  • Polyvalent mechanical bacterial lysate
  • Respiratory tract infections

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Pharmacology (medical)
  • Biochemistry, medical

Cite this

The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes. / Ricci, Rossella; Palmero, Candida; Bazurro, Gyada; Riccio, Anna Maria; Garelli, Valentina; Di Marco, Eddi; Cirillo, Carmelina; Braido, Fulvio; Canonica, Giorgio Walter; Melioli, Giovanni.

In: Pulmonary Pharmacology and Therapeutics, Vol. 27, No. 1, 02.2014, p. 109-113.

Research output: Contribution to journalArticle

Ricci, Rossella ; Palmero, Candida ; Bazurro, Gyada ; Riccio, Anna Maria ; Garelli, Valentina ; Di Marco, Eddi ; Cirillo, Carmelina ; Braido, Fulvio ; Canonica, Giorgio Walter ; Melioli, Giovanni. / The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes. In: Pulmonary Pharmacology and Therapeutics. 2014 ; Vol. 27, No. 1. pp. 109-113.
@article{335bdda5638c46699f85d76bda66e649,
title = "The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes",
abstract = "The administration of a polyvalent mechanical bacterial lysate (PMBL) in elderly patients with COPD has been shown to reduce the number of exacerbation. This is largely related to the involvement of cells belonging to the innate and the adaptive immune system (including dendritic cells, granulocytes, T and B lymphocytes and NK cells) that actively cooperate inducing the production of specific opsonizing antibodies directed to the antigens of PMBL. We have evaluated the production of antibodies directed to respiratory and systemic pathogens in a group of elderly COPD patients, recruited in a clinical trial, ancillary to a larger multicenter double blind, placebo-controlled, parallel-designed clinical trial in which patients were randomized to daily receive either PMBL or placebo. The treated group not only experienced a reduced number of seroconversion, but also, better controlled the number of infectious episodes and COPD exacerbations. It was thus evident that the administration of PMBL resulted not only effective in inducing the secretion of specific antibodies, but also effective in reducing the infectious episodes trough the potentiation of the antibody-mediated arm of the immune response.",
keywords = "Antibodies, Chronic obstructive pulmonary disease, Immune response, Polyvalent mechanical bacterial lysate, Respiratory tract infections",
author = "Rossella Ricci and Candida Palmero and Gyada Bazurro and Riccio, {Anna Maria} and Valentina Garelli and {Di Marco}, Eddi and Carmelina Cirillo and Fulvio Braido and Canonica, {Giorgio Walter} and Giovanni Melioli",
year = "2014",
month = "2",
doi = "10.1016/j.pupt.2013.05.006",
language = "English",
volume = "27",
pages = "109--113",
journal = "Pulmonary Pharmacology and Therapeutics",
issn = "1094-5539",
publisher = "Academic Press",
number = "1",

}

TY - JOUR

T1 - The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes

AU - Ricci, Rossella

AU - Palmero, Candida

AU - Bazurro, Gyada

AU - Riccio, Anna Maria

AU - Garelli, Valentina

AU - Di Marco, Eddi

AU - Cirillo, Carmelina

AU - Braido, Fulvio

AU - Canonica, Giorgio Walter

AU - Melioli, Giovanni

PY - 2014/2

Y1 - 2014/2

N2 - The administration of a polyvalent mechanical bacterial lysate (PMBL) in elderly patients with COPD has been shown to reduce the number of exacerbation. This is largely related to the involvement of cells belonging to the innate and the adaptive immune system (including dendritic cells, granulocytes, T and B lymphocytes and NK cells) that actively cooperate inducing the production of specific opsonizing antibodies directed to the antigens of PMBL. We have evaluated the production of antibodies directed to respiratory and systemic pathogens in a group of elderly COPD patients, recruited in a clinical trial, ancillary to a larger multicenter double blind, placebo-controlled, parallel-designed clinical trial in which patients were randomized to daily receive either PMBL or placebo. The treated group not only experienced a reduced number of seroconversion, but also, better controlled the number of infectious episodes and COPD exacerbations. It was thus evident that the administration of PMBL resulted not only effective in inducing the secretion of specific antibodies, but also effective in reducing the infectious episodes trough the potentiation of the antibody-mediated arm of the immune response.

AB - The administration of a polyvalent mechanical bacterial lysate (PMBL) in elderly patients with COPD has been shown to reduce the number of exacerbation. This is largely related to the involvement of cells belonging to the innate and the adaptive immune system (including dendritic cells, granulocytes, T and B lymphocytes and NK cells) that actively cooperate inducing the production of specific opsonizing antibodies directed to the antigens of PMBL. We have evaluated the production of antibodies directed to respiratory and systemic pathogens in a group of elderly COPD patients, recruited in a clinical trial, ancillary to a larger multicenter double blind, placebo-controlled, parallel-designed clinical trial in which patients were randomized to daily receive either PMBL or placebo. The treated group not only experienced a reduced number of seroconversion, but also, better controlled the number of infectious episodes and COPD exacerbations. It was thus evident that the administration of PMBL resulted not only effective in inducing the secretion of specific antibodies, but also effective in reducing the infectious episodes trough the potentiation of the antibody-mediated arm of the immune response.

KW - Antibodies

KW - Chronic obstructive pulmonary disease

KW - Immune response

KW - Polyvalent mechanical bacterial lysate

KW - Respiratory tract infections

UR - http://www.scopus.com/inward/record.url?scp=84892443572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892443572&partnerID=8YFLogxK

U2 - 10.1016/j.pupt.2013.05.006

DO - 10.1016/j.pupt.2013.05.006

M3 - Article

VL - 27

SP - 109

EP - 113

JO - Pulmonary Pharmacology and Therapeutics

JF - Pulmonary Pharmacology and Therapeutics

SN - 1094-5539

IS - 1

ER -